Inhalation Sciences’ subsidiary Ziccum announces approval for listing on Spotlight.

STOCKHOLM, SWEDEN – 14 September, 2018. Inhalation Sciences subsidiary Ziccum has been approved for listing on Stockholm stock market Spotlight, provided that the minimum limit of the company's new issue and the marketplace's proprietary spread requirements are met. The subscription period for the company's new share issue will begin on September 19 and continue until October 3, 2018. The first day of trading on Spotlight is scheduled for October 25, 2018.The new issue will take place with preference for Inhalation Sciences’ shareholders. Shareholders in Ziccum receive a unit right for each